1-(2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)pyrrolidine hydrochloride

Catalog No. :
ACWVXC997
CAS No. :
2760371-14-8
Molecular Formula :
C18H29BClNO3
Molecular Weight :
353.70

IUPAC Name:1-(2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)pyrrolidine hydrochloride

1-(2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)pyrrolidine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$150.00Login to see priceInquiryInquiry
100mg95%$215.00Login to see priceInquiryInquiry
250mg95%$303.00Login to see priceInquiryInquiry
1g95%$713.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)pyrrolidine hydrochloride
IUPAC Name1-(2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)pyrrolidine hydrochloride
Molecular FormulaC18H29BClNO3
Molecular Weight353.70
SMILESCC1(C)C(C)(C)OB(C2=CC(OCCN3CCCC3)=CC=C2)O1.[H]Cl
InChI KeyQTSKTJHETPUFSY-UHFFFAOYSA-N
SynonymPyrrolidine, 1-[2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]-, hydrochloride (1:1)
CAS No.2760371-14-8

Synthetic Route by SureRoute

1. ACWVXC997 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBQUE625 route compound structure diagram
    ACBQUE625214360-76-6 In Stock
  2. Plus
  3. ACRBKI205 route compound structure diagram
    ACRBKI2055050-41-9 In Stock
  4. Then
  5. ACWVXC997 route product structure diagram
    ACWVXC9972760371-14-8
Inquiry

2. ACWVXC997 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACWVXC997 route product structure diagram
    ACWVXC9972760371-14-8
Inquiry

Comments (0)